Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 601–700 of 806
Chen, B., Yang, S., & Su, W. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02362-6 · Cited by 4
“The intraocular immune-privileged environment, along with the permissive endothelial receptors, allows for the entry of malignant cells into the retina, with Bruch’s membrane serving as a barrier to further spread [81, 82].”
BackgroundReversal of Peripheral Iris Depigmentation Associated with Vogt-Koyanagi-Harada Disease
Tobaigy, M. F., AlBloushi, A. F., & Al-Dhibi, H. A. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2022.2161917 · Cited by 4
Hori, J. (2007) · Journal of The Society of Japanese Women Scientists · doi:10.5939/sjws.07002 · Cited by 4
Hyalocytes of the vitreous body and their role in ophthalmic pathology
Suetov, A. A., & Boiko, E. V. (2018) · Russian Annals of Ophthalmology · doi:10.17116/oftalma201813406194 · Cited by 4
Young, J. B., Buchberger, A. R., Bogaard, J. D., Luecke, L. B., Runquist, M. L., Skumatz, C. M. B., & Kassem, I. S. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.14.7 · Cited by 4
“34 In order to prevent excessive inflammation in the anterior segment of the eye, the AH contains factors that maintain an ocular immunosuppressive environment, such as transforming growth factor-beta 2 (TGF-β 2).”
Fas Expression in Conjunctival Epithelial Cells of Patients With Cystic Fibrosis
Mrugacz, M. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0111 · Cited by 4
“The expression of FasL in sites such as the eye and in some human carcinomas contributes the existence of immune privilege of these tissues by inducing apoptosis in Fas bearing immune cells (Griffi th and others 1995; Niehans and others 1997; Streilein 1999, 2003).”
Martínez, M. D. C. J., Mejía, H., Linares, M., Santacruz, C., Sánchez-Navarro, A., Suárez, R., & Garfias, Y. (2006) · Archivos de la Sociedad Española de Oftalmología · doi:10.4321/s0365-66912006000700007 · Cited by 4
“Nevertheless, we know that CECs do not express accessory molecules (1,4) and therefore we studied whether Ad5-infected CECs could induce B7 molecules on its surface.”
BackgroundTreatment of Post-operative Endophthalmitis
Spadea, L., & Fiasca, A. (2012) · European Ophthalmic Review · doi:10.17925/eor.2012.06.03.149 · Cited by 4
“Under normal circumstances, the blood–ocular barrier provides a natural resistance against invading organisms.(2)”
BackgroundLatanoprost does not affect immune privilege of corneal allografts
Wang, M., Kitahara, Y., Yoshida, A., & Hori, J. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.11.012 · Cited by 4
Ross, M., Sade, K., Obolensky, A., Averbukh, E., Desrosiers, M., Rosov, A., Dvir, H., Gootwine, E., Banin, E., Dalkara, D., et al. (2024) · Gene Therapy · doi:10.1038/s41434-024-00495-5 · Cited by 3
Advances and challenges of CRISPR/Cas gene editing for corneal diseases
Han, Y., Chen, R., & Shentu, X. (2025) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2025.11.002 · Cited by 5
“9,10 Our work provides a comprehensive review of the discovery and development of the CRISPR/Cas system, along with a comprehensive summary of its preclinical and clinical applications in corneal diseases.”
Kalashnikov, N., Pinchuk, L., & Vorstenbosch, J. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1748501 · Cited by 3
“However, the eye is considered an immune-privileged anatomic site where immune-mediated inflammation is naturally suppressed (Streilein, 2003; Niederkorn, 2006) and the cardiovascular system – more specifically, the heart valves (Hill et al., 2021) and the arterial tunica media (Tellides and Pober,…”
Synergistic antioxidant and gene supplementation for high-efficacy retinitis pigmentosa therapy
Wu, F., Wu, H., Yang, J., Wang, H., Pan, S., Zhan, Y., Liao, H., Chen, Y., Wu, X., & Yang, Z. (2026) · Science Advances · doi:10.1126/sciadv.aed0154 · Cited by 4
Bayanbayeva, Z., Yeltokova, M., Аkhmedyanova, Z., Khassenova, A., & Yermekova, K. (2022) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/11938 · Cited by 3
Booler, H. S., Ramos, M. F., Bartoe, J. T., & Teixeira, L. B. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-821046-8.00005-0 · Cited by 3
The neuroimmune interface in retinal regeneration
Bhattacharya, S., Deka, J., Avallone, T., & Todd, L. J. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101361 · Cited by 5
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
Kayo, D., Kanda, S., & Okubo, K. (2022) · Zoological Letters · doi:10.1186/s40851-022-00195-1 · Cited by 3
“The testes are known to have immune privilege and are more likely 48 to accept transplanted tissues (immune privilege site) and also to be the source of donor cells (immune 49 privilege tissue) (15).”
BackgroundResultEye trauma from a cat scratch with retention of the claw in the anterior chamber in a dog
Dulaurent, T., Steun, L., & Isard, P. (2023) · Open Veterinary Journal · doi:10.5455/ovj.2023.v13.i3.17 · Cited by 3
“…Williams et al., 2002; Paulsen and Kass, 2012; Borkar et al., 2021), the septic risk (Tanasescu et al., 1996; Oehler et al., 2009; Weinberg and Branda, 2010; Veraldi and Minuti, 2018), and the immune response involved (Wilcock and Peiffer, 1987; Streilein, 2003; Caspi, 2008; Perez et al., 2013).”
BackgroundDu, W., Huang, X., Liu, R., Ye, F., Li, X., Sun, B., & Li, H. (2023) · ONCOLOGIE · doi:10.1515/oncologie-2023-0372 · Cited by 4
“Speci fi cally,certainmalignanttumorsdeveloped in immune-privileged organs where immune cells struggle to in fi ltrate [41 – 43], resulted in weak expression of the TLS signature.”
BackgroundNew targets of nascent lymphatic vessels in ocular diseases
Wu, X., Ma, Y., Zhang, Z., Hou, T., & He, Y. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1374627 · Cited by 3
“Therefore, organisms have evolved speci fi c cells and molecules to form unique anatomical structures (such as blood – tissue barriers) that insulate the eye from in fl ammatory responses to prevent damage to vision, a phenomenon known as “ immune privilege ” (Streilein, 2003).”
BackgroundGokoffski, K. K., Washington, K. M., & Chuck, R. S. H. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.2.13 · Cited by 3
“25,26 Crucial aspects, such as early indicators for immune rejection, forms of rejection responses, clinical signs and laboratory findings, and modalities for monitoring and diagnosis are not fully understood.”
Wei, S. C., Cantor, A. J., Walleshauser, J., Mepani, R. J., Melton, K., Bans, A., Khekare, P., Gupta, S., Wang, J., Soares, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317387 · Cited by 3
“The ophthalmic disease space is an attractive area for applying these technologies [10–13], as the eye is an immune-privileged site [14] and safe, highly localized routes of direct administration to the retina have been adopted clinically [15].”
Niederkorn, J. Y., & Dana, M. R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370585-3.50012-1 · Cited by 3
21st Nantes Actualités Transplantation
Anegón, I., & Nguyen, T. H. (2016) · Transplantation · doi:10.1097/tp.0000000000001476 · Cited by 3
Special Anatomy and Pathology in Intraocular Microsurgery
Cursiefen, C., Kruse, F. E., Naumann, G. O. H., Jünemann, A. G. M., Schlötzer-Schrehardt, U. M., Joussen, A. M., Coupland, S. E., Tamm, E. R., Kirchhof, B., & Bornfeld, N. (2008) · Springer eBooks · doi:10.1007/978-3-540-68366-7_5 · Cited by 3
A Virtual Tissue Bank for Primary Central Nervous System Lymphomas in Immunocompetent Individuals
Ponzoni, M., Kwee, I., Mazzucchelli, L., Ferreri, A. J. M., Zucca, E., Doglioni, C., Cavalli, F., & Bertoni, F. (2007) · Pathobiology · doi:10.1159/000104455 · Cited by 3
Oshima, T., Sonoda, K., Nakao, S., Hijioka, K., Taniguchi, M., & Ishibashi, T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0284 · Cited by 3
“The mechanisms of ocular-type immunologic tolerance have been well studied in an experimental system, known as the anterior chamber-associated immune deviation (ACAID) animal model.(1) ACAID is a critically important dimension of the ability of the immune system to protect the eye from various types of inflammations,…”
BackgroundOphthalmic transplantology: Posterior segment of the eye – Part II
Nita, M., Strzałka‐Mrozik, B., Grzybowski, A. E., Romaniuk, W., & Mazurek, U. M. (2012) · Medical Science Monitor · doi:10.12659/msm.882868 · Cited by 3
“The cornea, anterior chamber, vitreous body, and subretinal space are “immune privileged” [2].”
Chen, P. W., Uno, T., & Ksander, B. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.02.009 · Cited by 3
Mansouri, K., Mahamed-Khosroushahi, L., & Rasouli, H. (2014) · doi:10.22110/jrps.v3i1.1344 · Cited by 3
Animal Models of Autoimmune Uveitis
Kielczewski, J. L., & Caspi, R. R. (2015) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-319-19434-9_6 · Cited by 4
Glaucoma Related Ocular Structure and Function
Yu, D., Cringle, S. J., & Morgan, W. H. (2019) · Springer eBooks · doi:10.1007/978-981-13-2733-9_1 · Cited by 5
Corneal transplantation and immunosuppressants
Akkaya, P. N. (2020) · Demiroglu Science University Florence Nightingale Transplantation Journal · doi:10.5606/dsufnjt.2019.001 · Cited by 3
“[10,11] Production of regulatory T cells (Treg) also play a role in composing the immunotolerance of the eye.[12] Corneal epithelial cells and the retinal pigment epithelium (RPE) also contribute to the formation of an immune barrier with tight junctions.”
BackgroundBacterial Endophthalmitis Following Cataract Surgery
Zegans, M. E., Toutain-Kidd, C. M., & Gilmore, M. S. (2008) · Springer series on biofilms · doi:10.1007/978-3-540-68119-9_8 · Cited by 3
“, Fas ligand) and soluble factors (TGFβ , α -melanocyte-stimulating hormone, vasoactive intestinal peptide, calcitonin gene-related peptide) contribute to immune privilege (Streilein 2003) .”
BackgroundUpdates on Corneal Xenotransplantation
Choi, H. J., Yoon, C. H., & Kim, M. K. (2019) · Current Ophthalmology Reports · doi:10.1007/s40135-019-00196-y · Cited by 3
Molecular Mechanisms of Immune Suppressive Microenvironment in the Cornea
Hori, J. (2009) · Cornea · doi:10.1097/ico.0b013e3181ae9b8b · Cited by 3
“ACAID is a well-known phenomenon in which antigenspecific peripheral tolerance is induced after antigen injection into the anterior chamber.(1,16) In the anterior chamber, which contains transforming growth factor (TGF)-b2 and thrombospondin (TSP)-1, the eye-derived APCs have captured antigens.”
BackgroundInfluentialLiang, A.-R., Feng, T., Gao, X., Zhao, B., & Chen, S. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303279463240220050158 · Cited by 4
Screening of a retinal-targeting Adeno-Associated Virus (AAV) via DNA shuffling
Yu, Y., Zhou, X., Peng, W., Wang, Y., Li, M., Zhu, Y., Song, Z., Wu, F., & Dong, C. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110245 · Cited by 3
Zhang, M., Xu, J., Qu, W., Gao, J., & Mo, Y. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2475626 · Cited by 3
“The immunological properties of the cornea are closely associated with its avascularity, Fas ligand expression, and secretion of immunosuppressive factors [8,9].”
The multiple roles of GM-CSF in autoimmune and autoinflammatory uveitis
Tao, T., Jiang, G., Su, Y., He, D., Zhu, L., Jiang, Q., & Su, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117090 · Cited by 3
Immunopathology of the Outer Retina: Crosstalk With the Immune System
Wildner, G., Gehrke, M., & Strauß, O. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.12.032 · Cited by 2
The Immune Biology of the Adrenal Gland Microenvironment and Its Role in Metastatic Progression
Liu, N. M., Sholevar, C. J., Karimzadeh, M., Uppuluri, J., Dongen, C. V., Graves, C. E., Campbell, M. J., Zamora, A. E., Judge, S. J., & Canter, R. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031153 · Cited by 4
“Examples of immune privilege include the eyes, the testicles, the pregnant uterus, and the central nervous system [145,146].”
Immune Tolerance and Autoimmune Uveoretinitis: the Role of the Ocular Microenvironment
Takeuchi, M. (2011) · Immunotherapy · doi:10.2217/imt.11.101 · Cited by 3
Alston, C. I. (2017) · Digital Archive @ GSU · doi:10.57709/8994924 · Cited by 2
Kono, D. H., & Theofilopoulos, A. N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00020-7 · Cited by 3
Chuckpaiwong, V., Jongkhajornpong, P., Rajsirisongsri, P., Sontichai, V., Nijvipakul, S., & Lekhanont, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276043 · Cited by 2
“The main mechanisms of immune privilege in normal cornea include the absence of blood and lymphatic vessels, low expression of major histocompatibility complex (MHC) and the ability to induce anterior chamber-associated immune deviation (ACAID), which all contribute to the lower rate of tissue rejection compared to so…”
BackgroundSchlemm's canal-selective Tie2/TEK knockdown induces sustained ocular hypertension in adult mice
Schwakopf, J., Romero, C. O., López, N. N., Millar, J. C., Vetter, M. L., & Bosco, A. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110114 · Cited by 5
Human cornea-derived mesenchymal stromal cells inhibit T cells through indoleamine 2,3 dioxygenase
Faircloth, T. U., Temple, S., Parr, R. N., Soma, A., Massoumi, H., Jalilian, E., Djalilian, A. R., Hematti, P., Rajan, D., & Chinnadurai, R. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.01.009 · Cited by 3
Cell Death of Tumor Melanocytes and Treatment Options
Koval, O. A., Zhilnikova, M., Balantaeva, M., Biryukov, M., & Atamanov, V. V. (2025) · Biocell · doi:10.32604/biocell.2025.059987 · Cited by 2
“For a deep understanding of the problem, you can read Streilein’s review at [9].”
Berkasova, N. L., Gavrilova, T. V., Shilov, Y. I., Владимировна, Ч. М., Медведева, С. Ю., Krochina, N. B., & Черешнев, В. А. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0086-6 · Cited by 2
Caspi, R. R., Dick, A. D., Forrester, J. V., Klein, R., Niederkorn, J. Y., Paulsen, F. P., Rosenbaum, J. T., Wakefield, D., & Zierhut, M. (2016) · Springer eBooks · doi:10.1007/978-3-540-75387-2_3 · Cited by 2
Treatment of Postoperative Endophthalmitis
Spadea, L. (2014) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2014.07.02.146 · Cited by 2
Yu, D., Morgan, W. H., Su, E., & Cringle, S. J. (2016) · Journal of Translational Science · doi:10.15761/jts.1000135 · Cited by 2
“Naturally, the pooling of aqueous humor beneath the conjunctiva and/or Tenon’s capsule forms a filtering bleb that has been considered a cornerstone of IOP control after GFS [14-19].”
BackgroundMesenchymal stem cell therapy for corneal diseases
Shukla, S., Tavakkoli, F., Singh, V., & Sangwan, V. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1215906 · Cited by 2
- Eye Anatomy, Physiology, and Ocular Barriers: Basic Considerations for Drug Delivery
Thassu, D., & Chader, G. J. (2012) · CRC Press eBooks · doi:10.1201/b12950-6 · Cited by 2
Cell Transplantation Therapy for Glaucoma
Zhang, X., Venugopalan, P., & Goldberg, J. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-49479-1_6 · Cited by 2
Regulation of Ion Transport Through Retinal Pigment Epithelium: Impact in Retinal Degeneration
Reichhart, N., & Strauß, O. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-55310-4_9 · Cited by 3
Kim, K.-W., Lee, H., Kim, H., & Kim, M. K. (2021) · Cells · doi:10.3390/cells10092210 · Cited by 2
“Although corneal transplantation is one of the most successful treatments [3], long-term graft rejection occurs in up to 40% of cases [4,5].”
BackgroundOphthalmic transplantology: Anterior segment of the eye – Part I
Nita, M., Strzałka‐Mrozik, B., Grzybowski, A. E., Romaniuk, W., & Mazurek, U. M. (2012) · Medical Science Monitor · doi:10.12659/msm.882723 · Cited by 2
“The cornea, anterior chamber, vitreous body, and subretinal space are “immune privileged” [2].”
Common principles of macrophage biology in blood–tissue barriers
Hiraga, S., & Masuda, T. (2024) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12812 · Cited by 2
“43 RPE cells exhibit a multitude of apical microvilli and are conjoined by tight junctions at their apical aspect.”
Chen, P. W., & Ksander, B. R. (2006) · Current Eye Research · doi:10.1080/02713680500477339 · Cited by 2
Time to study another variant of endothelial progenitor cells?
Rhéaume, É. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq216 · Cited by 2
Niederkorn, J. Y., & Ligocki, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.19006-x · Cited by 2
Baniewicz, E., Peterkin, N. L., Luby, M. L., Kern, K. C., Gottesman, R. F., Latour, L. L., & Turtzo, L. C. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123149 · Cited by 1
Unlocking Sanctuary Sites: The Efficacy of Brexucabtagene Autoleucel in Ocular B‐ ALL Relapse
Calabretta, L., Zappasodi, P., Biase, C. D., Picone, C., Roncoroni, E., Rossi, M., Bianchessi, A., Defrancesco, I., Zerbi, C., Ferrari, B., et al. (2024) · American Journal of Hematology · doi:10.1002/ajh.27572 · Cited by 1
“Another possibility is that CAR-T cells indirectly altered the permeability of BAqB's tight junctions and increased their paracellular permeation by stimulating cytokine production, such as IL-6 and IL-1 [21].”
Fundus Peripapillary Vascular Changes in Autism Spectrum Disorder: A Cross‐Sectional Study
Wang, Y., Wang, Y., Zhu, Z., Xia, Z., Wang, N., Li, M., Jiao, Z., Pan, N., Zhang, Y., Chen, Q., et al. (2025) · Autism Research · doi:10.1002/aur.70094 · Cited by 1
Wang, Y., Guo, P., Li, W., & Li, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595275 · Cited by 3
“Thus, immune privilege is vital for maintaining the stability and health of these organs (20).”
Wang, L., Wang, Q., Tang, Z., Wang, Y., Qu, Y., Wen, D., Zhong, Q., Hu, H., Liu, Y., & He, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1633833 · Cited by 3
“This poor outcome is attributed to the aggressive nature of hvKp infection combined with the eye being an immune-privileged site, where limited immune surveillance can allow unchecked bacterial growth and in fl ammation (Forrester and Xu, 2012; Streilein, 2003).”
Zhu, Q., Yang, S.-F., Gao, X., Chen, C.-W., Liu, Y., Xu, Z.-A., Pan, W.-J., Miao, H.-B., Zhang, X., Chi, Z., et al. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.12.15 · Cited by 1
“31 However, emerging evidence implicates innate immune components— neutrophils, mononuclear phagocytes, and microglia— as double-edged regulators of retinal homeostasis, 32 and their pathological activation has been implicated in diverse ocular disorders, including uveitis and corneal graft…”
Precision Is Not Enough: When Tools Outpace Translation in Ocular Gene Therapy
Elsayed, M. E. A. A., & MacLaren, R. E. (2026) · Genes · doi:10.3390/genes17030283 · Cited by 1
“The eye possesses a distinctive immunological milieu that supports gene therapy by limiting inflammatory responses and facilitating sustained transgene expression [57,58].”
InfluentialTherapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn
Bhujel, B., Lee, H. I., Chung, H. W., & Kim, J. Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083688 · Cited by 2
“In this context, suppression of pathological inflammatory and angiogenic responses may be more critical than rapid cellular proliferation [26–28].”
Abuhassan, Q., Saleh, K. A., Jyothi, S. R., Sahoo, R., Prakash, P., Mukherjee, G., Sinha, A., & Boyqulov, T. (2026) · Bioimpacts · doi:10.34172/bi.33219 · Cited by 1
“158,177,178 179-183 Intraocular resident immune cells, including macrophages and microglia, participate in active neuroimmune modulation through interactions with retinal neurons and glial cells, producing neuropeptides and inhibitory cytokines that suppress local inflammation.”
Liao, C. H. (2014) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000168 · Cited by 1
“We propose that these different inflammatory factor expressions might be due to the relatively differential immunological privilege between the brain and the spinal cord, where the spinal cord is not as immunologically privileged as the brain [7,8].”
BackgroundRose, J., May, M., & Williams, D. (2015) · Regenerative Medicine · doi:10.2217/rme.14.82 · Cited by 1
Metabolic Switch: A Phenotype or a Phenomenon?
Ramanujan, K., V (2014) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000161 · Cited by 2
Gronert, K. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.034 · Cited by 1
Stem Cell Applications in Corneal Regeneration and Wound Repair
Matthyssen, S., den Bogerd, B. V., Dhubhghaill, S. N., Koppen, C., & Zakaria, N. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-33720-3_13 · Cited by 2
Cataract surgery in a patient with apparent sodium hyaluronate allergy
Purgert, R. J., & Bala, E. (2019) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2018.11.012 · Cited by 1
Limbal Stem Cells and the Treatment of Limbal Stem Cell Deficiency
Ksander, B. R., Frank, M. H., & Frank, N. Y. (2018) · Fundamental biomedical technologies · doi:10.1007/978-3-319-98080-5_5 · Cited by 1
Gene Therapy for Choroidal Neovascularization
Lee, J. Y., & Yeo, J. H. (2020) · Springer eBooks · doi:10.1007/978-981-15-2213-0_28 · Cited by 1
Administration of Ocular Gene Therapy
Xu, D. N., Khan, M., Klufas, M. A., & Ho, A. C. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000365 · Cited by 1
Anti-inflammatory Strategies by Focusing on the Particularity of Ocular Immunity
Nabe, T., & Matsuda, M. (2021) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00158-3 · Cited by 1
Jabbari, A., Petukhova, L., & Christiano, A. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_29 · Cited by 1
Li, Y., Ke, W., Liu, X., Zhang, Q., Yu, N., Wang, K., & Chen, M. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.14.20 · Cited by 1
“Also, because of a low and appropriate level of virus injection, the immune-privileged structure of the eyeball, 27–29 and various susceptibility and resistance of between rats and mice, 30,31 the VAU models in our study differed from previously reported CMV-related retinitis, 12,27 HSV-related…”
ResultAn immunological window to the brain
Walsh, J. T., & Kipnis, J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00457-5 · Cited by 1
Gavrilova, T. V., Chuprina, V. V., Давыдова, Е. В., Shilov, Y. I., Владимировна, Ч. М., & Черешнев, В. А. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2008-2-3-239-244 · Cited by 1
Immune privilege as new therapeutic strategies for success of corneal transplantation
Kunishige, T., & Hori, J. (2013) · Inflammation and Regeneration · doi:10.2492/inflammregen.33.274 · Cited by 1
Stem Cell Transplant Immunology
Miller, K. K., & Schrepfer, S. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_12 · Cited by 1
Cultivated Cells in the Treatment of Corneal Diseases
Kinoshita, S., & Ueno, M. (2019) · Foundations of Corneal Disease · doi:10.1007/978-3-030-25335-6_18
Onur, İ. U. (2020) · Turkish Journal of Trauma and Emergency Surgery · doi:10.14744/tjtes.2019.88560
The role of retinal imaging in Alzheimer's disease
Chan, V. T. T., & Cheung, C. Y.-L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00022-7 · Cited by 1
Eye Anatomy, Physiology, and Ocular Barriers
Chader, G. J., & Thassu, D. (2012) · CRC Press eBooks · doi:10.1201/b12950-4 · Cited by 1
Characterization of Dendritic Cells and other Antigen‐presenting Cells in the Eye
Stein‐Streilein, J. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch6
Regulation of Immune Responses
Dana, R., & Foster, C. S. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50013-8 · Cited by 1
Wang, S. B. (2013) · eScholarship (California Digital Library) · Cited by 1
No secret hiding place on the ocular surface: what about after systemic SARS-CoV-2 infection?
Rokohl, A. C., Fätkenheuer, G., Cursiefen, C., & Heindl, L. M. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05230-z · Cited by 1
Corneal Wound Healing: Optical Clarity, Cytokines and Growth Factors, Matrix Metalloproteinases
Gordon, G. M., & Fini, M. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00137-7 · Cited by 1
Autoimmunity – Diseases of the EYE
Ghadiri, N., & Castillo, M. L. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00260-x · Cited by 2
Novel immunization strategies and interethnic differences in response to malaria infection
Arama, C. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.